Ocms Bio
UEI: X627KKM335K9
• CAGE: 8HP92
Overview
Awardee Type
Parent
Company Description
OCMS Bio is a Monoclonal Antibody Discovery Tools Company. Our proprietary technology On-Cell mAb Screening (OCMS™ pronounced as in "Occam's razor"), greatly speeds antibody discovery.
Name
Ocms Bio
Website
Headquarters
Penn Wynne, PA
United States
United States
Most Recent Award
June 1, 2023
Calculating
Federal grant recipient
OCMS BIO LLC
(UEI X627KKM335K9, CAGE 8HP92)
is headquartered in Penn Wynne PA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in June 2017 and
federally registered in
March 2020.
Federal Award Analysis
Ocms Bio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
OCMS BIO LLC
UEI
X627KKM335K9
CAGE Code
8HP92
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 27, 2017
Initial Registration
March 7, 2020
Last Registration
Jan. 17, 2025
Registration Activation
Jan. 22, 2024
Registration Expiration
Jan. 17, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported PSC
Accepts Credit Cards
Yes